Cardiogen for Cardiovascular Health & Heart Tissue Support — Bioregulators
Khavinson bioregulator peptide for cardiac tissue regeneration and cardiovascular system optimization.
Overview
Cardiogen is a Khavinson bioregulator peptide designed to support cardiovascular health through direct DNA-level gene regulation in cardiac and vascular tissues. It consists of short-chain peptides that bind to specific DNA sequences in heart cells to restore youthful patterns of gene expression and protein synthesis. Cardiogen targets the myocardium, blood vessels, and cardiovascular system to enhance cardiac function, support tissue repair after ischemic events, and optimize cardiovascular aging. Developed through decades of Russian research, it demonstrates cardioprotective effects in clinical studies.
Indications
- Cardiovascular health optimization in aging
- Post-myocardial infarction recovery support
- Chronic heart failure supportive therapy
- Coronary artery disease management
- Cardiac tissue repair and regeneration
- Blood pressure regulation support
- Athletic cardiovascular performance enhancement
Mechanism of Action
Age-related cardiac decline, post-ischemic damage, or chronic cardiovascular stress
Dosing
| Compound | Dose | Frequency | Notes |
|---|---|---|---|
| Cardiogen | 20 mg | Once daily | Typical dosing for cardiovascular health maintenance |
| Cardiogen | 20 mg | Twice daily for first month, then once daily | For post-MI recovery or cardiovascular disease |
Evidence Grade
GRADE C
Safety & Contraindications
- Emerging evidence - primarily Russian clinical studies
- No toxic or allergic reactions reported in available studies
- Should be used under physician supervision for cardiovascular conditions
- Not a replacement for standard cardiac medications
- Monitor blood pressure and cardiac function during use
- Contraindicated in acute cardiac emergency (seek immediate medical care)
- Safe for long-term use based on clinical data